WaveMan
WaveMan · Company
EUDA · Euda Health Holdings Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

EUDA EUDA Health (EUDA) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-health services · CIK 0001847846
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
1
13F, latest reported quarter

EUDA Health insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for EUDA Health Holdings Ltd in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
BUY
2022-11-25 SECtraded 2021-11-24
292,250
-
-76.4%
1 transaction on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
1 fund bought in last quarter
below 99% of Healthcare Services
Revenue
+70.0% year over year
more than 93% of Healthcare Services
Margin
-40.7% net margin
below 86% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
0.1% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
below 83% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch EUDA

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-66.5%12M
-88%-39%+10%+59%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns EUDA: institutional holders (13F)

13F holdings, latest reported quarter
$7.2K
$6.9K

Congress trades in EUDA

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

EUDA planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 1 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

EUDA financials

Revenue growth
+70.0%
XBRL, annual
Net margin
-40.7%
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$6.8M$40.1M$3.7M$9.8M
Gross profit$3.0M$762.2K$842.1K$870.0K
Operating income-$2.5M-$17.3M-$4.0M-$12.2M
Net income-$2.8M-$15.4M-$10.0M-$24.9M
EPS (diluted)-1.48-9.46-8.77-2.07
Operating cash flow-$2.4M-$2.0M-$2.9M-$1.5M
Cashn/an/a$189.0K$57.5K
SEC XBRL, fiscal years, as known on 2026-10-28

EUDA Stock Sonar score 3/7 axes

Find similar shapesCompare

EUDA ranks highest on growth (93rd percentile) and risk and compliance (88th), and lowest on institutional and government (1st), among Healthcare Services peers.

Growth
93
Inputs
  • Revenue growth, YoY+70.0% · 93 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
1
Inputs
  • Funds adding, latest quarter1 · 1 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
88
Inputs
  • Short interest, % of float+0.1% · 88 pct, sector of 93
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Insider conviction, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing